What is the GHS hazard classification for Nitromethane?
Nitromethane (CAS 75-52-5) is classified under EU CLP Annex VI as Flam. Liq. 3; Acute Tox. 4 * with signal word Warning. Hazard statements: H226; H302. Source: EU CLP Annex VI (ECHA).
Also known as: EINECS 200-876-6, Nitrometan, UNII-RU5WG8C3F4, CH3NO2, MeNO2
CAS 75-52-5
Nitromethane (CAS 75-52-5) is a chemical substance with GHS signal word Warning; key hazard signal: H226; H302. Key regulatory status: California Proposition 65, REACH registered, 4 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, IARC, ECHA REACH, CA Prop 65, ILO ICSC, OSHA, EPA TRI.
CAS, identifiers, formula, and alternate names for the matched substance record.
Carcinogenic hazard classification from IARC monograph evaluations.
| Group | Meaning | Evaluated | Volume |
|---|---|---|---|
| Group 2B | Possibly carcinogenic | 2000 | 77 |
California OEHHA listing status and toxicity category.
| Chemical | Toxicity Type | Cancer | Developmental | Listed |
|---|---|---|---|---|
| - | cancer | Yes | No | - |
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
| Hazard Class | H-Statements | Pictograms | Signal |
|---|---|---|---|
| Flam. Liq. 3; Acute Tox. 4 * | H226; H302 | GHS02; GHS07 | Warning |
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| Short-term Effects | The substance is irritating to the eyes, skin and respiratory tract. The substance may cause effects on the central nervous system. This may result in central nervous system depression. |
| Long-term Effects | Repeated or prolonged contact with skin may cause dermatitis. The substance may have effects on the peripheral nervous system, kidneys and liver. This may result in impaired functions. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation and by ingestion. |
Occupational exposure limits from OSHA, NIOSH, and ACGIH rows.
| Agency | Metric | Value | ppm | mg/m3 | Skin |
|---|---|---|---|---|---|
| OSHA | TWA | 100 ppm (250 mg/m³) | 100 | 250 | N |
| ACGIH | TWA | 20 ppm [1997] | 20 | - | N |
| CAL/OSHA | TWA | 2 ppm (5 mg/m³) | 2 | 5 | N |
| NIOSH | IDLH | 750 ppm | 750 | - | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| OEHHA Proposition 65 (3/2019) | STATE OF CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY | OEHHA Proposition 65 List |
| Europe; Personal care; restricted | European Commission | CosIng |
| OEHHA Proposition 65 (1/2023) | California Office of Environmental Health Hazard Assessment | OEHHA Proposition 65 List |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| =1.31 | mg/m3 | BMCL (10 HEC) | inhalation | Mouse | ToxValDB_PPRTV_(CPHEA) |
| =1.6 | mg/m3 | BMCL (10 HEC) | inhalation | Mouse | ToxValDB_PPRTV_(CPHEA) |
| AB39 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| AB39 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| AB39 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| AB39 | ug/day | California Proposition 65 NSRL | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| ABcancer | listing type | California Proposition 65 listing | - | - | California Proposition 65 |
| =39 | mg/m3 | DNEL local | inhalation | Human | ToxValDB_GESTIS_DNEL |
| =20 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| RU5WG8C3F4 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| RU5WG8C3F4 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| RU5WG8C3F4 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| RU5WG8C3F4 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 2B | IARC group | IARC carcinogenicity classification | - | - | IARC Monographs |
| 2 | unitless | IARC group | - | - | NTP_ICE_cancer |
| =940 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =2995.84 | mg/m3 | LEL | inhalation | Rat | ToxValDB_EPA_TSCA_8e |
| =182247 | mg/m3 | LEL | inhalation | Human | ToxValDB_DOE_Protective_Action_Criteria |
| 469.346421267894 | mg/m3/day | POLY-3 lowest dose | Inhalation | Mouse | NTP_ICE_cancer |
| 936.196319018405 | mg/m3/day | POLY-3 lowest dose | Inhalation | Mouse | NTP_ICE_cancer |
| 1872.39263803681 | mg/m3/day | POLY-3 lowest dose | Inhalation | Mouse | NTP_ICE_cancer |
| =0.004 | mg/m3 | RfC (provisional) | inhalation | Human | ToxValDB_PPRTV_(CPHEA) |
| =0.005 | mg/m3 | RfC (provisional) | inhalation | Human | ToxValDB_PPRTV_(CPHEA) |
| 375 | ppm | Top dose | Inhalation | Rat | NTP_ICE_cancer |
| 750 | ppm | Top dose | Inhalation | Mouse | NTP_ICE_cancer |
Showing 28 of 28 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Nitromethane | 200-876-6 | ECHA overview → |
TRI hazard and reporting flags for the matched chemical.
| Chemical | Category | Flags |
|---|---|---|
| Nitromethane | - | - |
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Nitromethane (CAS 75-52-5) is classified under EU CLP Annex VI as Flam. Liq. 3; Acute Tox. 4 * with signal word Warning. Hazard statements: H226; H302. Source: EU CLP Annex VI (ECHA).
Nitromethane has 28 NOAEL studies in the database. The lowest reported value is 1.31 mg/m3 via inhalation in Mouse. Source: ToxValDB_PPRTV_(CPHEA).
Nitromethane appears on 4 regulatory/inventory lists including OEHHA Proposition 65 (3/2019), Europe; Personal care; restricted, OEHHA Proposition 65 (1/2023), and 1 more. Source: EPA CPDat.
Nitromethane is classified by IARC as Group 2B — possibly carcinogenic to humans (evaluated 2000). Source: IARC Monographs on the Identification of Carcinogenic Hazards to Humans.
Yes, Nitromethane is listed under California Proposition 65 for cancer. Source: California OEHHA Proposition 65.
Occupational exposure limits for Nitromethane are set by OSHA, ACGIH, CAL/OSHA. 4 limit values from official agencies are documented in the database. Source: OSHA, NIOSH, ACGIH.
Yes, Nitromethane is also indexed as a cosmetic ingredient under the name NITROMETHANE. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, EPA DSSTox, IARC Monographs, ECHA REACH, California Proposition 65, ILO/WHO ICSC, OSHA/NIOSH/ACGIH, EPA Toxics Release Inventory, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Nitromethane also appears in cosmetics, pharmaceutical databases.